Search

everythinglearnresearchcommunity

for

Search:↓

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

Low iron levels may be linked to hair loss in women with chronic telogen effluvium.

A new topical solution safely reduces hair shedding by 38% on average by tightening a muscle in the scalp.

A patient experienced intense hair loss due to telogen effluvium after scalp contact dermatitis, but hair regrew completely within two months without further treatment.

CTE and FPHL are different hair loss types with unique causes.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Miliacin with polar lipids helps hair growth and improves hair loss in women.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

Trichobiolight effectively treats hair loss with 82.5% success.

Many patients with hair loss had low iron and vitamin D levels, but thyroid issues were not common.

Low ferritin levels might be linked to telogen effluvium, but vitamin D levels are not.

Researchers found that hair shedding happens mostly when new hair is growing and involves a unique process.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

EPR spectroscopy showed that spontaneous hair growth results in thicker skin and less pigmented hair than depilation-induced growth.

Telogen is an active phase with important biological processes, not a resting phase.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

The new visual scale is a quick and effective way to measure hair loss in women.

Two people lost a lot of hair because of epilepsy drugs, but their hair grew back after changing medication.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

About 40% of women without hair loss and 60% with hair loss experience a lot of hair shedding, especially those under 50 with long hair.

Poor sleep during the pandemic may increase stress and worsen hair loss conditions.

Low iron levels are linked to hair loss in women.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

Higher cannabis use may be linked to more severe hair loss.